IPO

Accretion Nutraveda Limited IPO

BSE SME

Listed On: Feb 4, 2026 at ₹ 191.0

₹ 258000 /2000 Shares
*Min Investment

Check Allotment

28 Jan, 2026

Open Date

30 Jan, 2026

Close Date

02 Feb, 2026

Allotment Date

04 Feb, 2026

Listing Date
Accretion Nutraveda IPO Live Subscription Details
View Subscription Details
QIB 1.01x
Individual 2.19x
NIIs 2.42x
BHNI 2.47x
SHNI 2.33x
Individual 2.19x
Total 1.91x
Last updated: 30 Jan 2026, 05:57 PM
Accretion Nutraveda IPO Issue Details
  • Issue Price ₹122-129 per equity share
  • Face Value ₹10 Per Equity Share
  • Total Issue Size 19,20,000 shares(aggregating up to ₹24.77 crore)
  • Fresh Share 19,20,000 shares(aggregating up to ₹24.77 crore)
  • Listing at BSE SME
  • List Price 191.0
  • Listing Date 2026-02-04
  • Lead Manager Sobhagya Capital Options Pvt.Ltd.
  • Registrar Kfin Technologies Ltd.
Market Lot Size

Investors can bid for a minimum of 2000 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors and HNI in terms of shares and amount.

Application Lots Shares Amount
Individual (min) 2 2000 ₹2,58,000
Individual(max) 2 2000 ₹2,58,000
SHNI(min) 3 3000 ₹3,87,000
SHNI(max) 7 7000 ₹9,03,000
BHNI(min) 8 8000 ₹10,32,000
Accretion Nutraveda IPO Reservation

Accretion Nutraveda IPO offers total 1920000 shares. Out of which 364000 (18.96%) allocated to QIB, 276000 (14.38%) allocated to NII,640000 (33.33%) allocated to RII, NA (NA%) allocated to employees and 544000 (28.33%) allocated to Anchor investors.

Investor Category Shares Offered Maximum Allottees
Anchor Investor Shares Offered 544000 (28.33%)
Market Maker Shares Offered 96000 (5%)
QIB Shares Offered 364000 (18.96%)
NII (HNI) Shares Offered 276000 (14.38%)
bNII > ₹10L 184000 (9.39%)
sNII < ₹10L 92000 (4.85%)
Individual Shares Offered 640000 (33.33%)
Total Shares Offered 1920000 (100%)
Accretion Nutraveda IPO Documents
DRHP
RHP
ANCHOR
Accretion Nutraveda IPO Details


Accretion Nutraveda Limited IPO is an SME IPO, priced at ₹122-129 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform. The IPO comprises a total issue of 19,20,000 equity shares, aggregating up to ₹24.77 crores..

The IPO bidding window is open from Jan 28, 2026 to Jan 30, 2026. The allotment is expected to be finalized on Feb 2, 2026, and the tentative listing date is Feb 4, 2026.

The minimum lot size for Individual investors is 2000 shares, with a minimum investment of ₹2,58,000.

Sobhagya Capital Options Pvt.Ltd. is acting as the lead manager to the issue. The registrar of the IPO is Kfin Technologies Ltd., and

Read More
Accretion Nutraveda IPO Subscription Analysis And Details
Retail
2.19x
QIB
1.01x
NII
2.42x
bNII
2.47x
sNII
2.33x
Total
1.91x
As on QIB NII
bNII   sNII 		Individual Total
Shares Offered / Reserved 3,64,000 2,76,000
1,84,000    92,000 		6,40,000 12,80,000
Day 1 28-01-26 05:00 PM
0.00 x 0.45 x
0.57 x   0.23 x 		0.21 x 0.20 x
Day 2 29-01-26 05:00 PM
0.99 x 0.99 x
1.00 x   0.98 x 		0.43 x 0.71 x
Day 3 30-01-26 05:00 PM
1.01 x 2.42 x
2.47 x   2.33 x 		2.19 x 1.91 x
Day 4 02-02-26 05:00 PM
1.01 x 2.42 x
2.47 x   2.33 x 		2.19 x 1.91 x
Total No of Applications
811
Subscription on the basis of Applications
Retail:2.19x BHNI:0.74x SHNI:2x
Accretion Nutraveda Valuations
EPS Pre IPO ₹4.91/-
EPS Post IPO ₹6.44/-
P/E Pre IPO 26.27
P/E Post IPO 20.02
ROE 81.22%
ROCE 36.98%
Debt/Equity 0.72
RoNW 48.85%
PAT Margin 16.33%
Price to Book Value 8.76
Market Cap. 93.40 Cr.
Accretion Nutraveda Company Financials
In Crs.
In Cr.
31-Mar-25 31-Mar-24 31-Mar-23
Assets 10.86 4.64 4.06
Revenue 16.06 5.20 3.07
Profit After Tax 2.61 0.82 0.28
Net Worth 5.35 1.08 0.26
Reserves & Surplus 4.86 0.72 -0.10
Total Borrowing 3.86 2.17 1.97
About Accretion Nutraveda Company

Incorporated in the year 2021, Accretion Nutraveda is engaged in the manfacturing of Ayurvedic and nutraceutical products in different dosage forms, which include tablets, capsules, oral liquids, powders, oils, and external preparations such as balms, creams, and gels.
The company is a Contract Development and Manufacturing Organization (CDMO) that caters to both local and international markets, including Sri Lanka, Singapore, and USA. It provides products that incorporate the wisdom of Ayurvedic science, along with the latest nutraceutical technology, to alleviate conditions such as liver care, women’s health, boneness and joint care, brain support, and respiratory health.

Business verticals:
Domestic Sales & Merchant Exports (Loan Licence Basis) - contributing 96.62% to total revenues in FY 2024-25.
Direct Exports– Contributing 38%, with a constant rise in It has a manufacturing plant in Gujarat which occupies around 10,763 sq. ft. and is well-equipped with latest infrastructure like 13 air handling units, processing areas, and quality control equipment. The plant is GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, and Halal certified along with FSSAI license.

Read More
Accretion Nutraveda - Promoter(s)

Mr. Mayur Popatlal Sojitra, Mr. Ankurkumar Shantilal Patel, Mr. Paraskumar Vinubhai Parmar, Mr. Hardik Mukundbhai Prajapati, Mr. Harshad Nanubhai Rathod & Mr. Vivek Ashok Kumar Patel

Pre Issue Share Holding : 100%

Post Issue Share Holding : 73.48%

Accretion Nutraveda IPO - Issue Objectives
1

Purchase of Machineries for Automation in existing Manufacturing unit

2

Purchase of Machineries for New Manufacturing Setup

3

Funding working capital requirements of our company

4

General corporate purposes

Contact Details

Accretion Nutraveda

27 Xcelon Industrial Park-1 Vasna-Chacharwadi, Ta-Sanand, Ahmedabad, Gujarat, 382213

+91 9904366177

compliance@accretionnutraveda.com

http://www.accretionnutraveda.com/

Registrar Contact Details

Kfin Technologies Limited

04067162222, 04079611000

citichemindia.ipo@kfintech.com

https://ipostatus.kfintech.com/